Table 3 |
||
|
Association of baseline levels of individual metalloproteinaises (MMPs) with all-cause mortality |
||
|
MMP (ng/ml) |
Hazard ratio (95% CI) |
P |
|
|
||
|
MMP-1 |
1.003 (0.99, 1.01) |
0.3 |
|
MMP-2 |
1.0005 (0.99, 1.001) |
0.7 |
|
MMP-3 |
0.999 (0.998, 1.000) |
0.07 |
|
MMP-8 |
1.006 (1.002, 1.01) |
0.003 |
|
MMP-9 |
1.005 (1.00, 1.001) |
0.04 |
|
|
||
|
Separate Cox proportional hazard regression analyses were carried out for each MMP with adjustment for age, sex and disease duration at baseline. |
||
|
Mattey et al. Arthritis Research & Therapy 2012 14:R204 doi:10.1186/ar4042 |
||